200 Clarendon Street 51st Floor,
Boston, Massachusetts 02116
United States
(617) 300-0161
www.locustwalk.com
Locust Walk Partners LLC is a corporate development advisory firm focused on serving biopharma companies and investors. Locust Walk Partners was established in 2008 and is based in Boston, Massachusetts.
| Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T |
|---|---|---|---|---|---|---|---|
| Buyside (0.4/yr) | 1 | 1 | - | 1 | - | - | 3 |
| Sellside (0.6/yr) | 1 | - | 1 | 1 | 1 | - | 4 |
| 7 | |||||||
| Target Company | Date | Value | Type |
|---|---|---|---|
| Sign-up to View | 2023-11-01 | 20M USD | Life Science |
| Sign-up to View | 2022-03-28 | 95M USD | Life Science |
| Sign-up to View | 2022-03-07 | 157M USD | Internet Software and Services |
| Sign-up to View | 2021-11-17 | - | Healthcare Services |
| Sign-up to View | 2020-06-28 | - | Life Science |
| Sign-up to View | 2019-12-26 | 665M USD | Life Science |
| Sign-up to View | 2016-12-23 | 9M USD | Life Science |
| View All >> | |||
| Sector | # | Value | |
|---|---|---|---|
| Life Science | Sign-up to View | ||
| Internet Software and Services | Sign-up to View | ||
| Healthcare Services | Sign-up to View | ||
| Total | Sign-up to View | ||
| State/Country | # | Value | |
|---|---|---|---|
| United States | Sign-up to View | ||
| California | Sign-up to View | ||
| Florida | Sign-up to View | ||
| Pennsylvania | Sign-up to View | ||
| United Kingdom | Sign-up to View | ||
| Domestic | Sign-up to View | ||
| Cross-border | Sign-up to View | ||
| Total | Sign-up to View | ||
| Type | # | Value | |
|---|---|---|---|
| Add-on Acquisition | Sign-up to View | ||
| Divestiture | Sign-up to View | ||
| Going Private | Sign-up to View | ||
| Venture | Sign-up to View | ||
| Total | Sign-up to View | ||
| Corporate (7) | Deals |
|---|---|
|
Sign-up to View |
2 |
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
| Value | # | TOTAL |
|---|---|---|
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
Xyphos Biosciences, Inc. $665M (2019-12-26) |
|
